Basic principles of physiologically-based pharmacokinetic (PBPK) modeling and its impact in streamlining the drug development process are reviewed.
Christopher Gibson
Advertisement
Christopher Gibson is distinguished scientist, Merck.
Articles by Christopher Gibson
Advertisement
Latest Updated Articles
Enabling the Virtual Human Through Physiologically-based Pharmacokinetic ModelingPublished: March 16th 2021 | Updated:
Advertisement
Advertisement
